Outgoing Anthem BC president speaks out
The 39% rate hikes at Anthem Blue Cross in California, which the Obama Administration used to argue the need for health reform, was fought internally by the company?s president, according to comments she made after resigning.
The 39% rate hikes at Anthem Blue Cross in California, which the Obama Administration used to argue the need for health reform, was fought internally by the company’s president, according to comments she made after resigning. Leslie Margolin is leaving the large insurer to head a coalition named Transforming Health Care, according to statements she recently made.
Anthem’s parent company, WellPoint Inc., came under fire for planning such dramatic rate hikes when its profits were up. U.S. Health and Human Services Secretary Kathleen Sebelius, described the hike as excessive and wrote to Margolin, demanding an explanation. Anthem later withdrew its rate increase plan, which would have averaged 25% for its nearly 800,000 policyholders in California, after discovering accounting errors. It now plans a 14% rate hike, on average, which is capped at 20%.
According to the Los Angeles Times, Margolin did not object to the hikes during testimony in February, but did speak against them in later engagements. In her comments to the press, she said her resignation was not linked to the rate hike controversy.
Margolin’s experience prior to joining Anthem in 2008 included service as a senior vice president of health plan and hospital operations at Oakland, Calif.-based Kaiser Permanente. She had also worked for CIGNA Corp. for 13 years.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
